A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium–Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study

Background: The Food and Drug Administration issued a warning on the risk of acute kidney injury and a signal of nephrolithiasis for patients using sodium–glucose co-transporter 2 inhibitors (SGLT2i). We performed a descriptive analysis on acute renal failure (ARF) and nephrolithiasis cases reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Frent, Ioana, Leucuta, Daniel, Bucsa, Camelia, Farcas, Andreea, Casoinic, Florin, Mogosan, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393368/
https://www.ncbi.nlm.nih.gov/pubmed/36003521
http://dx.doi.org/10.3389/fphar.2022.925805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393368/
https://www.ncbi.nlm.nih.gov/pubmed/36003521
http://dx.doi.org/10.3389/fphar.2022.925805

Ejemplares similares